Skip Navigation

Human Reproduction 2009 24(11):2675; doi:10.1093/humrep/dep368
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Hum. Reprod.
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Van Steirteghem, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Steirteghem, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Editor's Choice

André Van Steirteghem, Editor-in-Chief

E-mail: vansteirteghema@humanreproduction.co.uk

The first 10% of the full text of this article appears below.

Worldwide, hepatitis B is the most prevalent viral liver infection and the question arises as to how best to prevent infection of the unaffected partner and the future child when ART is used. Some countries advise against the use of ICSI because of the unknown risks and affects of chromosomal integration of hepatitis B virus (HBV) DNA in the . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in Hum. Reprod.:

To do or not to do: IVF and ICSI in chronic hepatitis B virus carriers
Suzanne P.M. Lutgens, Ewka C.M. Nelissen, Inge H.M. van Loo, Ger H. Koek, Josien G. Derhaag, and Gerard A.J. Dunselman
Hum. Reprod. 2009 24: 2676-2678. [Abstract] [FREE Full Text]  

What next for preimplantation genetic screening? High mitotic chromosome instability rate provides the biological basis for the low success rate
Evelyne Vanneste, Thierry Voet, Cindy Melotte, Sophie Debrock, Karen Sermon, Catherine Staessen, Inge Liebaers, Jean-Pierre Fryns, Thomas D'Hooghe, and Joris R. Vermeesch
Hum. Reprod. 2009 24: 2679-2682. [Abstract] [FREE Full Text]  

The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009
F. Zegers-Hochschild, G.D. Adamson, J. de Mouzon, O. Ishihara, R. Mansour, K. Nygren, E. Sullivan, S. van der Poel, and on behalf of ICMART and WHO
Hum. Reprod. 2009 24: 2683-2687. [Abstract] [FREE Full Text]  

Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial
F. Scarpellini and M. Sbracia
Hum. Reprod. 2009 24: 2703-2708. [Abstract] [FREE Full Text]  

Human embryonic stem cell lines derived from single blastomeres of two 4-cell stage embryos
Mieke Geens, Ileana Mateizel, Karen Sermon, Martine De Rycke, Claudia Spits, Greet Cauffman, Paul Devroey, Herman Tournaye, Inge Liebaers, and Hilde Van de Velde
Hum. Reprod. 2009 24: 2709-2717. [Abstract] [FREE Full Text]  

The value of measuring anti-Müllerian hormone in women with anovulatory polycystic ovary syndrome undergoing laparoscopic ovarian diathermy
S.A. Amer, T.C. Li, and W.L. Ledger
Hum. Reprod. 2009 24: 2760-2766. [Abstract] [FREE Full Text]  

The impact of social relations on the incidence of severe depressive symptoms among infertile women and men
R. Lund, C.S. Sejbaek, U. Christensen, and L. Schmidt
Hum. Reprod. 2009 24: 2810-2820. [Abstract] [FREE Full Text]  

Ovarian endocrine profile and long-term vascular patency following heterotopic autotransplantation of cryopreserved whole ovine ovaries
V.J. Onions, R. Webb, A.S. McNeilly, and B.K. Campbell
Hum. Reprod. 2009 24: 2845-2855. [Abstract] [FREE Full Text]  

Can 200 IU of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study
C. Blockeel, M. De Vos, W. Verpoest, D. Stoop, P. Haentjens, and P. Devroey
Hum. Reprod. 2009 24: 2910-2916. [Abstract] [FREE Full Text]